Literature DB >> 15763627

Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes.

W L J Hinrichs1, N N Sanders, S C De Smedt, J Demeester, H W Frijlink.   

Abstract

The aim of this study was to investigate whether the oligosaccharides dextran and inulin are able to prevent aggregation of lipoplexes based on 1,2-dioleoyl-3-trimethylammonium-propane and dioleoylphosphatidyl-ethanolamine with and without distearoylphosphatidylethanolamine-polyethyleneglycol (PEGylated and nonPEGylated lipoplexes, respectively) during storage. The lipoplexes, dispersed in the oligosaccharide solution were frozen and subsequently stored at subzero temperature or freeze dried and subsequently stored at 37 degrees C. When lipoplexes in frozen dispersions were stored below the glass transition temperature of the maximally freeze concentrated fraction (Tg') of the oligosaccharide solutions severe aggregation of the nonPEGylated lipoplexes was prevented for 3 months by both inulin and dextran. However, while dextran failed to stabilize the frozen PEGylated lipoplexes (as in most cases full aggregation occurred in short time) inulin successfully protected them against aggregation. Compared to dextran, inulin was also a superior lyoprotectant of PEGylated lipoplexes: during freeze drying and subsequent storage at 37 degrees C of the dried powders for 3 months the PEGylated lipoplexes maintained their original size when dispersed in inulin matrices while in dextran matrices they fully aggregated in most cases. It is hypothesized that the aggregation of the PEGylated lipoplexes in dextran solutions is caused by the well known incompatibility between dextrans and PEG. This is further supported by the observation that inulins and PEG are compatible. It is concluded that oligosaccharides can prevent severe aggregation of nonPEGylated lipoplexes. The same holds for PEGylated lipoplexes provided that the oligosaccharide is compatible with PEG. Finally, this work also shows that the higher Tg' of oligosaccharides makes them more versatile cryoprotectants than disaccharides like sucrose or trehalose as the frozen dispersions can be stored at higher temperatures for prolonged periods of time. Furthermore, it is proposed that oligosaccharides are also more versatile lyoprotectants than the disaccharides because they can be exposed to higher relative humidities without passing the glass transition temperature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763627     DOI: 10.1016/j.jconrel.2004.12.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  The use of disaccharides in inhibiting enzymatic activity loss and secondary structure changes in freeze-dried β-galactosidase during storage.

Authors:  Ville Petteri Heljo; Kirsi Jouppila; Timo Hatanpää; Anne M Juppo
Journal:  Pharm Res       Date:  2010-10-22       Impact factor: 4.200

2.  Physical Stability of Freeze-Dried Isomalt Diastereomer Mixtures.

Authors:  Anna-Kaisa Koskinen; Sara J Fraser-Miller; Johan P Bøtker; Ville P Heljo; Jonathan E Barnsley; Keith C Gordon; Clare J Strachan; Anne M Juppo
Journal:  Pharm Res       Date:  2016-04-08       Impact factor: 4.200

3.  The effect of water plasticization on the molecular mobility and crystallization tendency of amorphous disaccharides.

Authors:  Ville Petteri Heljo; Antti Nordberg; Mikko Tenho; Tommi Virtanen; Kirsi Jouppila; Jarno Salonen; Sirkka Liisa Maunu; Anne Mari Juppo
Journal:  Pharm Res       Date:  2011-12-28       Impact factor: 4.200

4.  The effects of lyophilization on the physico-chemical stability of sirolimus liposomes.

Authors:  Saeed Ghanbarzadeh; Hadi Valizadeh; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2013-02-07

5.  Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation.

Authors:  Susanne G L Quaak; John B A G Haanen; Jos H Beijnen; Bastiaan Nuijen
Journal:  AAPS PharmSciTech       Date:  2010-03-04       Impact factor: 3.246

Review 6.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

7.  Optimum Preparation Method for Self-Assembled PEGylation Nano-Adjuvant Based on Rehmannia glutinosa Polysaccharide and Its Immunological Effect on Macrophages.

Authors:  Yee Huang; Li Nan; Chenwen Xiao; Quanan Ji; Ke Li; Qiang Wei; Yan Liu; Guolian Bao
Journal:  Int J Nanomedicine       Date:  2019-11-29

Review 8.  Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.

Authors:  Silvia Franzé; Francesca Selmin; Elena Samaritani; Paola Minghetti; Francesco Cilurzo
Journal:  Pharmaceutics       Date:  2018-08-28       Impact factor: 6.321

9.  Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process.

Authors:  Bahez Gareb; Silke Posthumus; Max Beugeling; Pauline Koopmans; Daan J Touw; Gerard Dijkstra; Jos G W Kosterink; Henderik W Frijlink
Journal:  Pharmaceutics       Date:  2019-08-23       Impact factor: 6.321

Review 10.  Fructan and its relationship to abiotic stress tolerance in plants.

Authors:  David P Livingston; Dirk K Hincha; Arnd G Heyer
Journal:  Cell Mol Life Sci       Date:  2009-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.